dr. R.T. Urbanus

dr. R.T. Urbanus

Associate Professor
dr. R.T. Urbanus
  • Hematology/Van Creveldclinic

Research Programs

Circulatory Health




Rolf Urbanus is an associate professor of thrombosis and hemostasis at the Van Creveldkliniek and head of the minidonor dienst, a blood donation facility for research purposes at UMC Utrecht. He received his doctorate in medicine at Utrecht University. Dr. Urbanus has authored or coauthored more than 100 scientific publications on thrombosis and inherited bleeding disorders and is best known for his work on the auto-immune thrombotic disorder antiphospholipid syndrome. Dr. Urbanus is part of the steering committee of the Thrombocytopathy in the Netherlands (TiN) study, a nationwide study on inherited platelet disorders. He is currently a member of the editorial board of Seminars in Thrombosis and Hemostasis, a reviewer for numerous journals and serves in the scientific advisory board of the Netherlands Thrombosis Foundation.


Side Activities

Member of Scientific advisory board Netherlands Thrombosis Foundation (Trombosestichting)

Research Output (127)

DosEmi study protocol:a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

Donners Anouk, van der Zwet Konrad, Egberts Antoine C G, Fijnvandraat Karin, Mathôt Ron, Kruis Ilmar, Cnossen Marjon H, Schutgens Roger, Urbanus Rolf T, Fischer Kathelijn 26 Jun 2023, In: BMJ Open. 13

Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure:A Longitudinal Observational Study

Liesdek Omayra C.D., Urbanus Rolf T., De Maat Steven, De Heer Linda M., Ramjankhan Faiz Z., Sebastian Silvie A.E., Huisman Albert, De Jonge Nicolaas, Vink Aryan, Fischer Kathelijn, Maas Coen, Suyker Willem J.L., Schutgens Roger E.G. 1 May 2023, In: ASAIO journal. 69 , p. 438-444 7 p.

Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment—a prospective cohort study

van Dijk Wobke E.M., Poolen Geke C., Huisman Albert, Koene Harry R., Fijnheer Rob, Thielen Noortje, van Bladel Esther R., van Galen Karin P.M., Schutgens Roger E.G., Urbanus Rolf T. Apr 2023, In: Journal of Thrombosis and Haemostasis. 21 , p. 1020-1031 12 p.

Acquired blood platelet disorder in patients with end-stage heart failure after implantation of a continuous centrifugal-flow left ventricular assist device:A prospective cohort study

Liesdek Omayra C.D., Schutgens Roger E.G., de Heer Linda M., Ramjankhan Faiz Z., Sebastian Silvie A.E., Rohof Joline J., Suyker Willem J.L., Urbanus Rolf T. Feb 2023, In: Research and practice in thrombosis and haemostasis. 7 8 p.

Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing

Smit Bob, Hudig Francisca, Venhuizen Jan Hendrik, Haitjema Saskia, Limper Maarten, Urbanus Rolf, Huisman Albert 1 Jan 2023, In: Clinical and Applied Thrombosis/Hemostasis. 29 4 p.

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers

Noordermeer Tessa, Urbanus Rolf T., Wong Chong Y., Jansma Janna J., Wiersma Nynke M., Zivkovic Minka, Huisman Albert, Limper Maarten Jan 2023, In: Research and practice in thrombosis and haemostasis. 7 8 p.

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C

Noordermeer Tessa, Chemlal Soumaya, Jansma Janna J, van der Vegte Vossa, Schutgens Roger E G, Limper Maarten, de Groot Philip G, Meijers Joost C M, Urbanus Rolf T 2023, In: Journal of thrombosis and haemostasis : JTH. 21 , p. 2509-2518 10 p.

Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units:A retrospective cohort study

Noordermeer Tessa, Schutgens Roger E G, Visser Chantal, Rademaker Emma, de Maat Moniek P M, Jansen A J Gerard, Limper Maarten, Cremer Olaf L, Kruip Marieke J H A, Endeman Henrik, Maas Coen, de Laat Bas, Urbanus Rolf T, Aug 2022, In: Research and practice in thrombosis and haemostasis. 6

SYMPHONY consortium:Orchestrating personalized treatment for patients with bleeding disorders

Cnossen Marjon H, van Moort Iris, Reitsma Simone H, de Maat Moniek P M, Schutgens Roger E G, Urbanus Rolf T, Lingsma Hester F, Mathot Ron A A, Gouw Samantha C, Meijer Karina, Bredenoord Annelien L, van der Graaf Rieke, Fijnvandraat Karin, Meijer Alexander B, van den Akker Emile, Bierings Ruben, Eikenboom Jeroen C J, van den Biggelaar Maartje, de Haas Masja, Voorberg Jan, Leebeek Frank W G, 2 Jun 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 2001-2011 11 p.

Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A:A method validation study

Donners Anouk A.M.T., Gerencsér László, van der Elst Kim C.M., Egberts Toine C.G., de Maat Moniek P.M., Huisman Albert, Urbanus Rolf T., El Amrani Mohsin May 2022, In: Research and practice in thrombosis and haemostasis. 6 , p. 1-9

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not